One possible explanation for this discrepancy might be related to chronic type 2 airway inflammation induced by interleukin (IL)-13 in the airway epithelium, which could elevate ADAM17 expression, leading to the downregulation of ACE2 expression before COVID-19 infection in patients with asthma [48]. This evidence concerns the gene ACE2 and asthma.